Valuation: Zenotech Laboratories Limited

Market Cap 2.09B 21.98M 19.21M 17.66M 16.46M 31.22M 31.69M 212M 82.41M 1.03B 82.5M 80.73M 3.54B P/E 2024
43.5x
P/E 2025 56.5x
Enterprise Value 1.83B 19.17M 16.76M 15.4M 14.36M 27.23M 27.65M 185M 71.89M 897M 71.97M 70.43M 3.09B EV / Sales 2024
9.27x
EV / Sales 2025 7.42x
Free-Float
15.47%
Yield 2024 *
-
Yield 2025 -
04-29 Zenotech Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
01-23 Zenotech Laboratories Limited Announces Cessation of Chintan Jitendra Shah as Independent Director, Chairman of the Nomination and Remuneration Committee, Member of Audit Committee/ Stakeholders Relationship Committee and Reconstitution of Board Committees CI
01-23 Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
31/10/25 Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
25/09/25 Zenotech Laboratories Limited Announces Updation of Address of the Registered Office CI
28/07/25 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
30/03/25 Zenotech Laboratories Limited Announces Cessation of Kavita Rakesh Shah as Independent Director, with Effect from April 01, 2025 CI
28/01/25 Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
23/10/24 Zenotech Laboratories Limited Appoints Dr. Sachin Laxmanappa Gavandare as Chief Executive Officer (Key Managerial Personnel) CI
23/10/24 Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
26/07/24 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 CI
17/05/24 Zenotech Laboratories Limited Announces Resignation of Devendra Chandrakant Shenvi Kenkre as Chief Executive Officer, Effective August 12, 2024 CI
01/05/24 Zenotech Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
1 day+3.42%
1 week+0.35%
Current month+3.85%
1 month+2.87%
3 months+7.69%
6 months-2.98%
Current year-0.61%
1 week 42
Extreme 42
46.45
1 month 41.94
Extreme 41.94
48.47
Current year 33.55
Extreme 33.55
50.93
1 year 33.55
Extreme 33.55
66
3 years 33.55
Extreme 33.55
107.79
5 years 33.55
Extreme 33.55
107.79
10 years 12
Extreme 12
107.79
Manager TitleAgeSince
Chief Executive Officer - 23/10/2024
Director of Finance/CFO - 06/02/2014
Compliance Officer 46 11/03/2016
Director TitleAgeSince
Director/Board Member 58 08/07/2015
Chairman 67 -
Director/Board Member 42 27/01/2016
Change 5-day change 1-year change 3-year change Capi.($)
+3.42%+0.35%-28.25%-16.47% 28.46M
+3.45%+7.65%+55.77%+158.84% 1,082B
-1.16%+7.42%+69.09%+58.92% 633B
-0.77%+7.37%+36.87%+93.77% 461B
-0.35%+1.85%+31.30%+24.86% 339B
-0.56%+1.17%+41.96%+39.64% 301B
-0.08%+1.49%+32.40%+44.75% 292B
-1.54%+2.58%-25.52%-39.75% 225B
+3.55%+6.05%+26.04%+68.52% 202B
+0.40%+6.00%+17.72%+70.33% 163B
Average +1.68%+2.37%+25.74%+50.34% 369.97B
Weighted average by Cap. +1.37%+1.96%+42.23%+81.71%

Financials

2024 2025
Net sales 368M 3.87M 3.38M 3.11M 2.89M 5.49M 5.57M 37.29M 14.49M 181M 14.51M 14.2M 623M 391M 4.11M 3.59M 3.3M 3.08M 5.83M 5.92M 39.61M 15.4M 192M 15.41M 15.08M 662M
Net income 82.99M 872K 762K 700K 653K 1.24M 1.26M 8.41M 3.27M 40.79M 3.27M 3.2M 141M 56.13M 590K 515K 474K 441K 837K 850K 5.69M 2.21M 27.59M 2.21M 2.17M 95.07M
Net Debt -197M -2.07M -1.81M -1.66M -1.55M -2.94M -2.98M -19.94M -7.75M -96.78M -7.76M -7.59M -333M -267M -2.8M -2.45M -2.25M -2.1M -3.98M -4.04M -27.05M -10.52M -131M -10.53M -10.3M -452M
Logo Zenotech Laboratories Limited
Zenotech Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in a business of manufacture and marketing of pharmaceuticals products. The Company is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing oncology, biotechnology and general injectables products. The Company’s injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology. Its product includes granulocyte-colony stimulating factor (GCSF) and Granulocyte-macrophage colony-stimulating factor (GMCSF). The Company has a manufacturing facility at Turkapally village, Shamirpet Mandal, Telangana.
Employees
228
Date Price Change Volume
03/07/26 45.91 +3.42% 10,914
02/07/26 ₹44.39 +1.74% 5,997
01/07/26 ₹43.63 -1.31% 5,672
30/06/26 ₹44.21 -0.87% 6,257
29/06/26 ₹44.60 -2.51% 5,946
  1. Stock Market
  2. Stocks
  3. ZENOTECH6 Stock